483 Fougera Pharmaceuticals Jun 2012

483 Fougera Pharmaceuticals Jun 2012

Alice Tsao FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued 4 inspectional observations (via FDA 483) on 15 Jun 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 15 Jun 2012
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart